サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606402

Cri-du-chat症候群治療市場：治療法別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年

Cri-du-chat Syndrome Treatment Market, By Treatment, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 301 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
Cri-du-chat症候群治療市場：治療法別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年
出版日: 2024年11月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

Cri-du-chat症候群治療市場は2023年に11億9,043万米ドルと評価され、2024年から2032年にかけて14.10%のCAGRで拡大しました。

Cri-du-chat症候群治療市場-市場力学

Cri-du-chat症候群のような遺伝性疾患や発達障害の有病率の上昇は、市場拡大に大きく寄与すると予想されます。自閉症スペクトラム障害（ASD）や知的障害のような状態を包含する発達障害の増加は、Cri-du-chat症候群の発生の増加と関連しています。米国国立衛生研究所によると、Cri-du-chat症候群は新生児の約2万人から5万人に1人の割合で発症し、すべての民族に存在するといいます。さらに、テレヘルスやオンライン治療プラットフォームの出現は、市場開拓の新たな機会を提供しています。とはいえ、標準化された治療プロトコルが存在しないことが、市場の進展を妨げる可能性もあります。

Cri-du-chat症候群治療市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約14.10%のCAGRで年間成長すると予測されています。

治療法別では、理学療法が2023年に最大市場シェアを示すと予測されます。

エンドユーザー別では、病院、専門クリニックが2023年の主要治療です。

地域別では、北米が2023年の主要収益源でした。

Cri-du-chat症候群治療市場-セグメンテーション分析：

世界のCri-du-chat症候群治療市場は、治療法、エンドユーザー、地域に基づいてセグメント化されます。

市場は治療法によって3つのカテゴリーに区分される：理学療法、言語療法、作業療法です。この中では、理学療法が優位な地位を占めています。理学療法の主な目的は、運動能力、筋力、協調性を高めることです。また、身体障害を管理し、自立心を養うという重要な役割を担っています。

市場はエンドユーザーによって、病院と専門クリニック、その他の事業体の2つに分類されます。市場の成長は、主に病院と専門クリニックが牽引しています。これらの施設におけるCri-du-chat症候群治療市場は、意識の高まり、患者ケアへの集学的アプローチ、技術の進歩に後押しされ、進展しています。

Cri-du-chat症候群治療市場-地理的洞察

同市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカを含む広範な地域にまたがっています。これらの地域はさらに、貢献している国に基づいて分類されています。北米は、理学療法治療に対する意識の高まりから、市場で主導的な地位を占めています。Cri-du-chat症候群の管理における理学療法やその他の治療アプローチの重要性について、ヘルスケア専門家や家族の間で理解が高まっています。Physical Therapy Statistics &Factsによると、米国では現在38,800の理学療法クリニックが営業しています。欧州もまた、ヘルスケア支出の増加に牽引され、大幅な市場成長を経験しています。

Cri-du-chat症候群治療市場-競合情勢：

Cri-du-chat症候群（CdCS）の治療には、病院、専門クリニック、製薬会社、治療サービスのプロバイダーなど、多様な投資家が関わっています。これらの事業体間の競争は、この遺伝的疾患に罹患した人々に効果的な管理ソリューションを提供することが急務であることに起因しています。競合他社は、Cri-du-chat症候群患者特有のニーズを満たすために特別に設計された、革新的でエビデンスに基づいた治療戦略の開発にますます力を注いでいます。このアプローチでは、複数の治療法を統合して全体的な治療レジメンを構築することが多いです。このような競合環境の中では、教育的リソースの提供とともに、患者や家族の参加を重視する組織が際立った存在となる可能性が高いです。

目次

第1章 Cri-du-chat症候群治療市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 Cri-du-chat症候群治療主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 Cri-du-chat症候群治療産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 Cri-du-chat症候群治療市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 Cri-du-chat症候群治療市場情勢

  • 2022年、Cri-du-chat症候群治療市場シェア分析
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 Cri-du-chat症候群治療市場-治療法別

  • 概要
    • セグメントシェア分析
    • 理学療法
    • 言語療法
    • 作業療法

第8章 Cri-du-chat症候群治療市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 病院および専門クリニック
    • その他

第9章 Cri-du-chat症候群治療市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- Cri-du-chat症候群治療業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Centogene NV
    • Eurofins Scientific
    • F. Hoffmann-La Roche Ltd
    • Invitae Corporation
    • Illumina Inc
    • Natera Inc
    • PerkinElmer Inc
    • Quest Diagnostics Incorporated
    • Precigen Inc.
    • LifeCodexx GmbH
    • Ravgen
    • GeneDx, LLC
    • Asper Biogene LLC
    • Others

第11章 アナリストの全方位展望

目次
Product Code: ANV4209

REPORT HIGHLIGHT

The Cri-du-chat Syndrome Treatment Market was valued at USD 1,190.43 million in 2023 and expanded at a CAGR of 14.10% from 2024 to 2032.

Cri du chat syndrome is an uncommon genetic condition resulting from deletions on a specific chromosome. The management of Cri du Chat syndrome is comprehensive, emphasizing symptom control, developmental support, and the improvement of life quality for those impacted. Approximately 10% of individuals with this condition inherit the chromosomal anomaly from a parent who does not exhibit symptoms. In such cases, the parent possesses a chromosomal rearrangement known as a balanced translocation.

Cri-du-chat Syndrome Treatment Market- Market Dynamics

The rising prevalence of genetic and developmental disorders, such as Cri-du-chat syndrome, is expected to contribute significantly to market expansion. This increase in developmental disorders, which encompasses conditions like autism spectrum disorder (ASD) and intellectual disabilities, is associated with the growing occurrence of Cri-du-chat syndrome. According to the National Institutes of Health, Cri-du-chat syndrome affects approximately 1 in 20,000 to 50,000 newborns and is present across all ethnic groups. Additionally, the emergence of Telehealth and online therapy platforms offers new opportunities for market development. Nevertheless, the absence of standardized treatment protocols may hinder market progress.

Cri-du-chat Syndrome Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.10% over the forecast period (2024-2032)

Based on Treatment segmentation, Physiotherapy was predicted to show maximum market share in the year 2023

Based on End-User segmentation, Hospitals, and specialty clinics was the leading Treatment in 2023

Based on region, North America was the leading revenue generator in 2023

Cri-du-chat Syndrome Treatment Market- Segmentation Analysis:

The Global Cri-du-chat Syndrome Treatment Market is segmented based on Treatment, End-User, and Region.

The market is segmented into three distinct categories according to treatment modalities: Physiotherapy, Speech Therapy, and Occupational Therapy. Among these, Physiotherapy holds a predominant position. The primary objective of Physiotherapy is to enhance motor skills, strength, and coordination. Additionally, it plays a crucial role in managing physical disabilities and fostering independence.

The market is segmented into two primary categories according to End-User: Hospitals and specialty clinics, along with other entities. The growth of the market is predominantly led by hospitals and specialty clinics. The treatment market for Cri-du-chat syndrome within these facilities is progressing, fueled by heightened awareness, a multidisciplinary approach to patient care, and technological advancements.

Cri-du-chat Syndrome Treatment Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further categorized based on the contributing nations. North America holds a leading position in the market, attributed to an increased awareness of physiotherapy treatments. There has been a notable surge in understanding among healthcare professionals and families regarding the significance of physiotherapy and other therapeutic approaches in managing Cri-du-chat syndrome. According to Physical Therapy Statistics & Facts, there are currently 38,800 physical therapy clinics operating in the United States. In 2020, the average annual earnings for physical therapists were USD 74,972. Europe is also experiencing substantial market growth, driven by rising healthcare expenditures.

Cri-du-chat Syndrome Treatment Market- Competitive Landscape:

The treatment landscape for Cri-du-chat syndrome (CdCS) encompasses a diverse array of investors, including hospitals, specialized clinics, pharmaceutical firms, and providers of therapeutic services. The competition among these entities is fueled by the imperative to deliver effective management solutions for individuals affected by this genetic condition. Competitors are increasingly concentrating on the development of innovative, evidence-based treatment strategies that are specifically designed to meet the unique needs of patients with Cri-du-chat syndrome. This approach often involves the integration of multiple therapies to create a holistic treatment regimen. Organizations that emphasize patient and family involvement, along with the provision of educational resources, are likely to distinguish themselves within this competitive environment.

Recent Developments:

Eurofins companies have been at the forefront of advancing prenatal screening tests designed to identify conditions that may impact the fetus, thereby aiding in healthcare decision-making both before and following childbirth.

April 25, 2022, Illumina, Inc. a prominent global entity in DNA sequencing and array-based technologies, has recently disclosed a partnership with Hannover Medical School in Germany. This collaboration aims to introduce whole-genome sequencing (WGS) for critically ill pediatric patients who are suspected of having genetic or rare diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Centogene N.V.
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • Invitae Corporation
  • Illumina Inc
  • Natera Inc
  • PerkinElmer Inc
  • Quest Diagnostics Incorporated
  • Precigen Inc.
  • LifeCodexx GmbH
  • Ravgen
  • GeneDx, LLC
  • Asper Biogene LLC
  • Others

GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Physiotherapy
  • Speech therapy
  • Occupational therapy

GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and specialty clinics
  • Others

GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cri-du-chat Syndrome Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cri-du-chat Syndrome Treatment Market Snippet by Treatment
    • 2.1.2. Cri-du-chat Syndrome Treatment Market Snippet by End-User
    • 2.1.3. Cri-du-chat Syndrome Treatment Market Snippet by Country
    • 2.1.4. Cri-du-chat Syndrome Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Cri-du-chat Syndrome Treatment Key Market Trends

  • 3.1. Cri-du-chat Syndrome Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cri-du-chat Syndrome Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cri-du-chat Syndrome Treatment Market Opportunities
  • 3.4. Cri-du-chat Syndrome Treatment Market Future Trends

4. Cri-du-chat Syndrome Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cri-du-chat Syndrome Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cri-du-chat Syndrome Treatment Market Landscape

  • 6.1. Cri-du-chat Syndrome Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cri-du-chat Syndrome Treatment Market - By Treatment

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
    • 7.1.2. Physiotherapy
    • 7.1.3. Speech therapy
    • 7.1.4. Occupational therapy

8. Cri-du-chat Syndrome Treatment Market - By End-User

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 8.1.2. Hospitals and specialty clinics
    • 8.1.3. Others

9. Cri-du-chat Syndrome Treatment Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Cri-du-chat Syndrome Treatment Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Cri-du-chat Syndrome Treatment Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Cri-du-chat Syndrome Treatment Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Cri-du-chat Syndrome Treatment Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Cri-du-chat Syndrome Treatment Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Cri-du-chat Syndrome Treatment Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Centogene N.V.
    • 10.2.2. Eurofins Scientific
    • 10.2.3. F. Hoffmann-La Roche Ltd
    • 10.2.4. Invitae Corporation
    • 10.2.5. Illumina Inc
    • 10.2.6. Natera Inc
    • 10.2.7. PerkinElmer Inc
    • 10.2.8. Quest Diagnostics Incorporated
    • 10.2.9. Precigen Inc.
    • 10.2.10. LifeCodexx GmbH
    • 10.2.11. Ravgen
    • 10.2.12. GeneDx, LLC
    • 10.2.13. Asper Biogene LLC
    • 10.2.14. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us